We previously identified STRN3-containing PP2A phosphatase as a negative regulator of MST1/2 kinases (i.e., Hippo) in gastric cancer (GC), opening the possibility of selectively targeting the PP2Aa–STRN3–MST1/2 axis to recover Hippo signaling against cancer. The gene discussed is PTPA; the disease is cancer.